Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Sahastara Remedy Extract in Healthy Volunteers
NCT02568059Phase 1Completed
- Sponsor
- Thammasat University
- Start
- Dec 2015
- Primary completion
- Sep 2016
- Modality
- PE (Plant Extract)
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Sahastara in osteoarthritis (OA) (2 arms), sponsored by Thammasat University. Primary endpoint: Clinical safety evaluated by History taking, Patient diary note, Physical Examination and Laboratory test at 14 days. Started Dec 2015; status: completed.
02
Drugs
Sahastara
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02568059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02568059.